IL-15 and SCF fail to induce NK dierentiation and proliferation of CD34 + hematopoietic progenitors from chronic myeloid leukemia patients in contrast to normal stem cells although, both normal and leukemic CD34 + cells display comparable expression of c-kit or IL-15 receptor subunits. Interestingly, confocal microscopy analysis revealed that leukemic and most normal CD34 + cells produce and secrete IL-15, as shown by its tracking through the Golgi apparatus and early endosomes. However, only leukemic progenitors express the membrane bound IL-15. Colocalization and internalization of IL-15Rb/gc and IL-15Ra/gc complexes indicated that IL-15 was speci®cally uptaken by leukemic progenitors. We also demonstrated that in both normal and leukemic progenitors, the signaling kinase Jak3 is constitutively pre-associated with the gc chain. Anti-IL-15 neutralizing mAb treatment resulted in downregulation of gc chain and disruption of gc/Jak3 interaction in normal but had no eect in leukemic progenitors. Our results suggest the existence in both normal and leukemic CD34 + cells of a constitutive production of a bioactive IL-15 that does not lead to NK dierentiation and further indicate that membrane bound IL-15 and constitutive activation of gc are hallmarks of leukemic progenitors.
Introduction
Chronic myeloid leukemia (CML) is a malignant clonal disorder of hematopoietic stem cells. The neoplastic cells are characterized by the presence of a new hybrid gene bcr/abl (Nowell and Hungerford, 1960) , displaying several variants that are transduced in proteins of 190 ± 230 KD. These proteins promote the permanent activation of stem cell proliferation through their high tyrosine kinase activity (Lugo et al., 1990) . So far, allogeneic bone marrow transplantation (BMT) is the treatment that results in complete and de®nitive disappearance of the bcr/abl transcript. However, such treatment is limited to young adults and the disponibility of a HLA identical donor and thus concerns only 15% of CML patients. In this model, whether the immune eect against leukemia is mediated by T, NK cells or a combination of both cells remains unknown. Nevertheless, it has been shown that alpha-interferon (IFN-a) used alone or in combination with other drugs leads to durable remission in selected patients supporting a possible role of NK cells (Kantarjian et al., 1993; Wetzler et al., 1995) . In this context, transplantation of autologous Ph1 negative stem cells could represent an alternative treatment in which NK cells may constitute the main cytolytic immune cells capable of mediating the GVL eect . Furthermore, since peripheral NK cells from CML patients display altered functionality (Cervantes et al., 1996; Verfaillie et al., 1990) , dierentiation of NK cells from progenitors could overcome these defects and allow the generation of highly cytotoxic NK cells.
To evaluate this hypothesis, we have investigated the NK potential of hematopoietic precursors from CML patients. For this purpose we used a previously described in vitro system to dierentiate NK cells from CD34 + stem cells using combination of SCF and IL-15 (Carayol et al., 1998) . IL-15 is produced by bone marrow stromal cells and recently, it was found as the most powerful cytokine to drive CD34 + cell dierentiation into NK cells (Carson et al., 1994 (Carson et al., , 1997 Mingari et al., 1997 (Caligiuri et al., 1990) but both subsets display similar in vitro response to IL-2 and IL-15 (Carson et al., 1994) .
IL-2 and IL-15 share the IL-2/15Rb and gc chains, display similar eects on T cell proliferation, NK cell activation and induction of Ig by activated B cells . They also share a common signaling through the Jak1/Jak3 and Stat3/Stat5 pathways (Johnston et al., 1995; Lin et al., 1995) . In addition, IL-2 and IL-15 receptors have their own a chain, which belongs to the same family receptor. However, in contrast to IL-2Ra, IL-15Ra binds to IL-15 with a very high anity and displays a wider cellular distribution.
Two IL-15 isoforms have been identi®ed that dier in the length of the peptide signal (Meazza et al., 1996) .
The alternative IL-15 isoform, with the small peptide, is not secreted but rather stored intracellularly where it appears in the nucleus and cytoplasm (Tagaya, 1997) . The standard isoform, characterized by the longer signal peptide, is localized in the endoplasmic reticulum and may be detected in the Golgi apparatus and early endosomes. It follows therefore a pathway leading to its secretion and/or to its expression as a membrane bound biologically active form (Barzegar et al., 1998; Musso et al., 1999) .
In the present study, we provided evidence indicating that leukemic CD34 + cells failed to proliferate and dierentiate in NK cells in response to exogeneous SCF and IL-15 and suggesting that leukemic progenitors display an endogenous deregulated IL-15 pathway that may be associated with their failure to dierentiate into NK eectors.
Results
In vitro NK cell differentiation impairment of CML CD34 progenitors in response to SCF and IL-15
Immunoselected leukemic CD34 + cells were cultured in the presence of SCF and IL-15, as previously described (Carayol et al., 1998) . The results obtained from the 20 patients are summarized in Table 1. Compared to  normal CD34 + cell cultures that resulted in high proliferation (660 ± 90, n=3), proliferation index of CML NK progenitors were deeply decreased. Indeed, no proliferation was observed in cultures from 11/20 patients. For 8/20 patients, low proliferation was observed (62 to 68). Among these patients, only one (UPN 9), showed a proliferative index of 30.
Data in Table 1 also indicate that the expression of CD56 by dierentiated cells was observed in 9/20 samples. From 4/9 (UPN 4, 6, 11 and 19), 60 ± 80% of the cells exhibited high CD56 expression (MFI410 3 ) although the proliferative response (index 2 ± 8) was much lower than from normals. The ®ve other cultures displayed low CD56 staining (MFI510 2 ) expressed by varying percentages of cells (10 ± 99%). It should also be stressed that no dierence in NK dierentiation was observed between cultures initiated using bone marrow stem cells or peripheral blood stem cells. This suggests that NK dierentiation was altered in leukemic CD34 + progenitors from both origins. Functionally, CD56 bright cells lysed K562 targets, although with a lower eciency than NK cells derived from normal progenitors, whereas CD56 low and CD56 7 cells did not exert any cytotoxic activity against K562 (Figure 1 ) or p46 redirected of P815 (data not shown). These data imply that the lytic potential of these eectors clearly correlate with the intensity of their CD56 expression, further con®rming our previous observation (Carayol et al., 1998) .
Expression of c-kit and IL-15 receptors chains on CML CD34
+ progenitors
In order to understand the lack of NK dierentiation from CML CD34 + cells, expression of c-kit and IL-15R by normal and pathologic CD34 + cells were compared. RT ± PCR analysis revealed the presence of gc and IL-2/15Rb and IL-15Ra chains mRNA in both normal and leukemic progenitors (Figure 2 ). Flow cytometry analysis showed a similar cell surface distribution for the b and gc chains in normal and leukemic cells as summarized in Table 2 , suggesting that there was no obvious alteration of IL-2/15Rb and gc chain membrane expression in leukemic progenitors. Both normal and CML CD34 + cells expressed c-kit, suggesting that both cell types should display normal responsiveness to exogenous SCF (Table 2) .
Endogenous IL-15 is produced and internalized by CD34 + from CML Based on the crucial role of IL-15 in the NK dierentiation from CD34 + cells, we asked whether the altered dierentiation observed in CML patients involved the IL-15 pathway. For this purpose, staining with anti-IL-15 and with mAb speci®c for the dierent cellular organelles and confocal microscopy analyses, that allowed precise analysis of IL-15 distribution in the dierent cell compartments, were performed in normal and leukemic CD34 + cells. As shown in Figure 3b , most leukemic CD34 + cells contained IL-15 protein. The diuse green staining demonstrated the presence of an intracellular IL-15 protein and the yellow spots showed that some IL-15 is colocalized in the Golgi apparatus (red staining), indicating its potential to be secreted. The presence of IL-15 inside the early endosomes (de®ned using FITCtransferrin) was also evidenced. In the overlay picture (Figure 3c ), the red staining con®rms that all the cells expressed a cytoplasmic endogenous IL-15 and the intense localized yellow staining in three out of ®ve cells showed its presence inside the early endosomes, suggesting that endogenous Il-15 was constitutively produced and re-trapped by surrounding cells. Confocal microscopy analysis of serial optical sections Figure 3d ) revealed that Il-15 was found both at the cell membrane and in the internal sections con®rming its internalization and suggesting the presence of autocrine/paracrine loops. As depicted in Figure 3f , in normal cells from some donors, IL-15 was produced but not secreted as shown by confocal analysis. Normal CD34 + cells exhibited an IL-15 staining only in the internal sections, and a membrane bound IL-15 was only detected in a large cell (probably a contaminating macrophage). Alternatively, in other donors CD34 + progenitors behaved as leukemic ones, but with a major dierence resulting from the lack of membrane bound IL-15.
Expression of IL-15R on leukemic CD34
+ cells
The presence of IL-15Ra/gc and IL-2/15Rb/gc complexes as well as their internalization in basal conditions were also studied. Confocal analysis ( Figure  4a ) showed that IL-15Ra and gc chains were expressed, colocalized and internalized as shown by the presence of the yellow staining in the internal sections. A similar behavior was observed for the b/gc complex ( Figure  4b ).
In normal stem cells, the analysis of IL-15R components showed the absence of co-localization between the b and the gc as well as between a and the gc chains in the majority of these cells (Figure 4c and d). This conclusion was also supported by the quantitative analysis of the green and red¯uorescence intensities versus intracellular distribution (data not shown). However, addition of exogenous IL-15 (10 ng/ ml) induced within 15 min the assembly of the b/gc complex as shown by appearance of a yellow staining (Figure 4e ).
Anti-IL-15 antibody disrupted the IL-15 signaling pathway in normal stem cells but not in leukemic progenitors
To further analyse the defect of CML stem cells in their response to the dierentiating eect of IL-15, early events of IL-15 signaling, namely the interaction of Jak3 with the gc chain was studied by confocal microscopy. Results on Figure 5a showed that in normal CD34 + cells, in basal culture conditions, a colocalization (yellow staining) of Jak3 (red staining) with gc chain (green staining) was observed. Side-side analysis of the previous overlay picture demonstrated that both proteins were strongly co-expressed as depicted by the presence of green and red staining (Figure 5b ). Overnight treatment with anti-IL-15 neutralizing mab inhibited gc chain expression (disappearance of green staining) and induced downregulation of Jak3 probably due to its attenuated recruitment as a consequence of lower gc expression. Thus anti-IL-15 treatment caused the disruption of the gc/Jak3 complex in normal CD34 + cells (Figure 5c ). In CML CD34 + cells, gc and Jak3 are associated in basal conditions (Figure 5d ) and treatment with anti-IL-15 neutralizing mAb did not induce downregulation of gc resulting in colocalization of green and red¯uorescence in leukemic cells after treatment with anti-IL-15 (Figure 5e ).
Discussion
Autologous transplantation of stem cells constitutes an alternative to allogeneic bone marrow transplantation for CML patients. Therefore, analysis of the NK dierentiation potential in these precursors is of major interest. For this purpose, we have investigated NK dierentiation of CD34 + progenitors from CML patients in early chronic phase since normal primitive hematopoietic progenitors are more frequent than their leukemic counterparts in newly diagnosed patients We ®rst asked whether the inability of CD34 + cells from CML patients to dierentiate in NK cells resulted from an altered IL-15R expression on these cells or alternatively was associated with an altered signal transduction in response to exogenous IL-15. IL-15R expression analysis did not reveal a signi®cant dierence between normal and leukemic cells. In addition, confocal analysis showed that IL-15R a/gc and IL-2/15R b/gc complexes colocalized and internalized, evidencing the presence of a functional receptor in CML CD34 + cells, in the absence of exogeneous IL-15.
It has been suggested that IL-15 should be considered as a juxtacrine factor secreted and ecient in very low amount undetectable by ELISA or biological assays (Alleva et al., 1997; Barzegar et al., 1998) . This hypothesis is supported by recent data showing that CD34 + progenitors NK dierentiation involved IL-15, produced in minute quantities by bone marrow stromal cells and required intimate cell/cell contacts (Carson et al., 1994; Mrozek et al., 1996) . Therefore, in order to better understand the absence of NK dierentiation from CML CD34 + cells, we compared the intracellular localization and tracking of IL-15 in the leukemic progenitors to that observed in normals. We demonstrated herein an endogenous production of IL-15 by CML CD34 + cells. The detection of some IL-15 inside the Golgi apparatus strongly suggests that this cytokine follows the intracellular routing common to other secreted cyto- (Musso et al., 1999) . Thus, in leukemic stem cells, endogenous IL-15 could be functional through dierent mechanisms involving alternatively a particular steric conformation, represented by membrane bound cytokine, and/or a secreted form circulating in the microenvironment and active at very low concentrations. The membrane bound form could be associated to a more complex co-signaling yielded by the association with other surface molecules. This would suggest that both forms display dierential biological activities, as described for other cytokines (Grell et al., 1995) . The present studies demonstrate that IL-15 secreted by normal CD34 + cells is not ecient to trigger NK dierentiation. However, in these cells, endogenous IL-15 appears to be essential for the expression of the gc chain and for its association with the signaling molecule Jak3, since exposure to neutralizing anti-IL- 15 mAb resulted in inhibition of the expression of the gc chain and its interaction with Jak3. This ®ts with a recent report indicating that IL-2 is able to stabilize the gc chain mRNA and subsequently to improve its expression at the surface of human monocytes (Bosco et al., 1994) . By contrast, in leukemic cells anti-IL-15 mAb fails to induce the down regulation of the gc chain or the disruption of its interaction with Jak3. Therefore, in leukemic cells, the constitutive expression of the gc chain as well as the continuous production of IL-15 would explain the sustained proliferation of leukemic precursors in vivo and their survival. All the patients included in this study were positive for bcr/abl, and thus the alteration of IL-15 dierentiation pathway could be an indirect consequence of the bcr/abl protein expression and its subsequent enhanced tyrosine kinase activity. In this respect, bcr/ Abl expression through NF-KB activation (Reuther et al., 1998) may be involved in IL-15 transcription (Washizu et al., 1998) . It is interesting to note that bcr/abl constitute targets to the development of selective tyrosine kinase inhibitors. The avaibility of such inhibitors able to block bcr/abl tyrosine kinase constitutes a promising approach to the treatment of CML (Druker and Lydon, 2000; Lecoutre et al., 1999) . Whether such compounds could reverse the constitutive activation of gc/Jak3 in leukemic progenitors should be determined. In summary, our results show the existence in both normal and leukemic CML CD34 + cells of a constitutive production and intercellular tracking of very low concentrations of bioactive IL-15 that does not lead to NK dierentiation. Addition of exogeneous IL-15 and SCF redirects this IL-15-dependent metabolic pathway towards NK dierentiation in normal but not in leukemic progenitors.
Materials and methods

Hematological characteristics of CML patients and selection of CD34 + progenitors
Twenty CML patients in chronic phase at diagnostic were included in the present study. Peripheral blood (30 ± 40 ml) was obtained from 14 out of the 20 patients, and bone marrow samples (2 ml) from six patients. Mononuclear cells were isolated after centrifugation on Ficoll gradient (Lymphoprep Nicomed Pharma SA, Oslo, Norway). Selection of CD34 + cells was performed by immunomagnetic selection (Miltenyi, Tebu, France) on mononuclear cells labeled with a mAb speci®c for the QBEND10 epitope of the CD34 antigen as previously described (Carayol et al., 1998 + cells/ml were implanted in aMEM medium supplemented with 10% human serum (Institut Jacques Boy, Reims, France), 5% FCS (Stem Cell Technologies, Vancouver, Canada), recombinant stem cell factor (SCF) 20 ng/ml and IL-15 (10 ng/ml) both provided by Diaclone (BesancË on, France). In some experiments, Flt3-L (gift from L Zitvogel, IGR, Villejuif) and IL-2 (Roussel Uclaf, France) were used. Some cultures were set up in absence of stromal cells. Cultures were maintained for 4 ± 5 weeks at 378C with 5% CO 2 atmosphere and medium was renewed weekly.
Phenotypic analysis of differentiated NK cells
Two weeks after the onset of the culture and weekly thereafter, cells were analysed to evaluate the number and phenotype of dierentiated cells. Several PE-Cy5 or PE coupled mAbs were used, allowing double¯uorescence analysis: CD34 (IgG1), CD38 (IgG1), CD56 (IgG1), CD122 (IL-2/15R b chain, IgG1), CD132 (gc chain, IgG1), CD117 (SCF-R, IgG1) purchased from Immunotech (Marseille, France). Ten ml of each mAb were used to label 5610 4 cells. Cells were incubated for 20 min in ice, washed three times with PBS and ®xed before analysis on a FACS-Sort (Becton Dickinson, Pont de Claix, France). Background levels were measured using isotypic controls. For two-color labeling analysis, compensation was set up with single stained samples. Low forward scatter elements (red cells or debris) were excluded from the analysis and 10 000 events were collected and analysed using the Cellquest software (Becton Dickinson).
Assessment of the cytolytic activity of cultured NK cells
Dierentiated NK cells were tested for cytotoxicity against the NK sensitive cell line K562 in a 4 h Cr 51 release assay (Carayol et al., 1998) . Eector to target ratios ranged from 10 : 1 to 2 : 1. All determinations were performed in triplicate and lysis percentages were determined as previously described. Cytotlytic activity of CD56 + cells was also assessed by redirected lysis of P815 murine cells assay in presence of anti-p46 mAb (gift from A Moretta).
Analysis of IL-15R transcripts by RT ± PCR
Extraction of total RNA from CD34 + cells, cDNA synthesis and ampli®cation reactions were performed as previously described (Carayol et al., 1998) . The oligonucleotide primers and conditions used for ampli®cations of IL-15R transcripts and control actin were those previously described (Barzegar et al., 1998) . The ampli®ed products were analysed after electrophoresis on ethidium bromide agarose gels.
Confocal microscopy analysis
For double staining of IL-15 and the endosomal compartment, immunoselected CD34 + cells were preincubated in serum free IMDM and then treated with Fluoresceintransferrin (FITC-Tf, Molecular Probes, Eugene, OR, USA) at 378C for 30 min. Subsequently, cells were washed, and permeabilized with ORTHOpermea®x (Ortho Diagnostic Systems Inc., Raritan, NJ, USA) for 45 min at room temperature. Then cells were stained with polyclonal rabbit anti-human IL-15 antibody (p15, Preprotech, Inc Rocky Hill, NJ, USA), incubated for 30 min with a biotinylated-goat anti-rabbit (Immunotech, Marseille, France) and ®nally exposed for 30 min to streptavidine-RED 670 (strep-RED 670 , Gibco).
A rabbit polyclonal antiserum, anti-Rab6 (gift from Dr B Goud) was used to stain the medial and cis Golgi compartments. After cell ®xation and permeabilization, double indirect immuno¯uorescence was performed. Cells were ®rst stained with anti-IL-15 mAb M111 (purchased from Genzyme), followed by FITC-GAM incubation. They were then labeled by anti-Rab6 followed by biotinylated-GAR incubation and ®nally by strep-RED 670 incubation.
For double staining of each IL-15R components and Jak3, the following reagents were used: anti-IL-15Ra mAb M160 (gift from T Trout, Immunex, Seattle, WA, USA), anti-IL2Rb mAb CF-1 (gift from Y Jaques, U463 INSERM, Nantes), rat anti-IL-2Rg mAb TUGh4 (Pharmingen, San Diego, CA, USA) and rabbit anti-Jak3 antiserum (Upstate Biotechnology, Lake Placid, NY, USA). Cells were stained with various antibodies at room temperature followed by FITC-GAM and PE-GAR incubation.
Stained cells were washed with PBS, cytocentrifuged in a cytospin 3 (Shandon, Pittsburg, PA, USA) and analysed by laser scanning confocal microscopy. For inhibition experiments, cells were incubated overnight with anti-IL-15 neutralizing mab M111 (20 mg/ml) at 378C.
Laser scanning microscopy (LSCM) and three dimensional image (3D) reconstruction Labeled specimens were scanned with an ACAS 570 Interactive Laser Cytometer (Meridian Instruments, Inc Okemos, MI, USA) equipped with confocal optics. The system consisted of a 5W argon ion laser tuned to 488 nm, an Olympus IMT-2 inverted microscope with a 1006 oil immersion objective (NA1.3) Z axis control, an XY scanning stage and a variable pinhole aperture all under 80486 computer coordination. The ACAS 570 was set up in uorescence mode. FITC and strep-RED670 were excited at 488 nm. The computer converts¯uorescence intensity into color as output image. The excitation was done at 20 NW power and the ®lter constitution for emission detection was the conventionally used for FITC 520 nm BP and strep-RED 670 nm BP. To obtain a good resolution, pinhole and photomultiplier voltage was set at 40 and 25% respectively.
